Integrating Cordant’s suite of drug testing, pharmacy and data analytics solutions can help promote patient safety, engagement and adherence to treatment protocols and increases visibility into patient behavior for early intervention.
Cordant’s on-site buprenorphine distribution program in conjunction with your treatment protocol can help improve patient adherence to their treatment plan.
The on-site program demonstrates significantly higher retention rates for patients early in treatment¹
Patients are more likely to make their office visits when buprenorphine is dispensed on-site²
Fewer patients have drug-related ER visits when utilizing the on-site distribution program²
Patients experienced fewer relapse events3
1Analysis of 154 patients 90 days or less in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 154 patients 90 days or less in treatment participating in on-site program; Nov. 2017–Oct. 2018
2Analysis of 236 patients in treatment prior to on-site program; Nov. 2016–Oct. 2017 and 300 patients in treatment participating in on-site program; Nov. 2017–Oct. 2018
Please complete this form to request more information about our behavioral health pharmacy service.